Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

27.07
Delayed Data
As of Sep 04
 +0.35 / +1.31%
Today’s Change
12.27
Today|||52-Week Range
38.10
+65.87%
Year-to-Date
No recent news for Coherus BioSciences Inc.

Today’s Trading

Previous close26.72
Today’s open26.56
Day’s range25.24 - 27.15
Volume242,520
Average volume (3 months)315,993
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-10.14%
Earnings growth (this year)+43.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,030.72%
P/E ratioNM
Price/Sales4.30
Price/Book13.48

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.72-1.59%
AIMTAimmune Therapeutics...-0.94-3.99%
RTRXRetrophin Inc+0.34+1.29%
RLYPRelypsa Inc+1.06+4.74%
Data as of 3:59pm ET, 09/04/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.1M
Annual profit (last year)-$87.1M
Net profit margin-280.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers